Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT set at €51.00 by JPMorgan Chase & Co.

0

Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) received a target price of €51.00 ($51.52) per JPMorgan Chase & Co. in a report released Thursday, Borsen Zeitung reports. JPMorgan Chase & Co.The company’s price target would suggest a potential upside of 14.12% from the company’s previous close.

Other analysts have also recently published research reports on the company. Deutsche Bank Rese… set a target price of €58.00 ($58.59) on Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 research note. Berenberg Bank set a target price of €82.20 ($83.03) on Fresenius Medical Care AG & Co. KGaA in a Monday, June 27 research note. Warburg Research set a target price of €62.00 ($62.63) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, May 10 research note. Jefferies Financial Group set a target price of €64.00 ($64.65) on Fresenius Medical Care AG & Co. KGaA in a Monday, July 4 research note. Finally, Barclays set a target price of €68.00 ($68.69) on Fresenius Medical Care AG & Co. KGaA in a Wednesday June 22 research note.

Fresenius Medical Care AG & Co. KGaA Stock up 1.7%

Shares of Action Fresenius Medical Care AG & Co. KGaA opened at €44.69 ($45.14) on Thursday. The company’s fifty-day moving average price is €50.61 and its two-hundred-day moving average price is €56.23. The company has a debt ratio of 91.78, a current ratio of 1.26 and a quick ratio of 0.79. The company has a market capitalization of $13.10 billion and a P/E ratio of 14.32. Fresenius Medical Care AG & Co. KGaA has a 1-year minimum of €43.53 ($43.97) and a 1-year maximum of €69.96 ($70.67).

Fresenius Medical Care AG & Co. KGaA Company Profile

(Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Read more



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.